title: The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation.
abstract: Varicella-zoster virus (VZV) is the first of the human herpesviruses to be attenuated and subsequently approved as a live vaccine to prevent varicella and herpes zoster. Both the attenuated VZV vaccine, called vaccine Oka or vOka, and the parental strain pOka have been completely sequenced. Yet the specific determinants of attenuation are uncertain. The open reading frame (ORF) with the most single nucleotide polymorphisms (SNPs), ORF62, encodes the regulatory protein IE62, but IE62 studies have failed to define a specific SNP associated with attenuation. We have completed next-generation sequencing of the VZV Ellen genome, a strain known to be highly attenuated by its very limited replication in human skin xenografts in the SCID mouse model of VZV pathogenesis. A comparative analysis of the Ellen sequence with all other complete VZV sequences was extremely informative. In particular, an unexpected finding was a stop codon mutation in Ellen ORF0 (herpes simplex virus UL56 homolog) identical to one found in vOka, combined with the absence of polymorphisms in most Ellen ORFs that were known to be mutated in vOka. The mutated ORF0 protein was also imaged in both two dimensions and three dimensions by confocal microscopy. The probability of two VZV strains not connected by a recent common ancestor having an identical ORF0 SNP by chance would be 1 × 10(-8), in other words, extremely unlikely. Taken together, these bioinformatics analyses strongly suggest that the stop codon ORF0 SNP is one of the determinants of the attenuation genotype of live VZV vaccines.
authors: National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
authors: Geoffrey A
authors: GA
authors: Peters
authors: Shaun D
authors: SD
authors: Tyler
authors: John E
authors: JE
authors: Carpenter
authors: Wallen
authors: W
authors: Jackson
authors: Yasuko
authors: Y
authors: Mori
authors: Ann M
authors: AM
authors: Arvin
authors: Charles
authors: C
authors: Grose
mesh_terms: D000818:Animals; D018388:Codon, Terminator; D019295:Computational Biology / Q000379:methods; D005347:Fibroblasts / Q000378:metabolism; D016679:Genome, Viral; D005838:Genotype; D014645:Herpesvirus 3, Human / Q000235:genetics*; D006801:Humans; D017874:Immediate-Early Proteins / Q000378:metabolism; D047468:Immunoprecipitation; D051379:Mice; D016513:Mice, SCID; D018613:Microscopy, Confocal / Q000379:methods; D008969:Molecular Sequence Data; D009154:Mutation; D016366:Open Reading Frames; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D017422:Sequence Analysis, DNA; D015534:Trans-Activators / Q000378:metabolism; D014613:Vaccines, Attenuated / Q000235:genetics*; D014759:Viral Envelope Proteins / Q000378:metabolism
chemical_list: D018388:Codon, Terminator; C074221:IE62 protein, Human herpesvirus 3; D017874:Immediate-Early Proteins; D015534:Trans-Activators; D014613:Vaccines, Attenuated; D014759:Viral Envelope Proteins